EUVIMEDEUVIMED entdecken
Crossref

Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018–2023

Angela J Forbes, Andrew S Day, Chris M A Frampton, Richard B Gearry

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-024-08811-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Angela J Forbes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8140, New Zealand. angela.forbes@postgrad.ot…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: New diagnoses of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), can highlight health system burden and potentially give clues to disease aetiology. This population-based study aimed to measure the annual incidence of IBD over six years (2018-2023) in the Canterbury region of New Zealand. METHODS: The medical records from public and private gastroenterology clinics were examined for new patients with a confirmed diagnosis of IBD from 1 January 2018 to 31 December 2023. Demographic and disease information (including the Montreal phenotype) was gathered in a secure database. Information was collected prospectively from 2021 to 2023 and retrospectively from 2018 to 2020. RESULTS: The incidence of IBD in 2023 was 30.1 per 100,000 person-years (95% CI 25.9-34.7), CD: 14.8 (95% CI 11.9-18.1), and UC: 14.5 (95% CI 11.7-17.7). The average age was 35.0 years (SD 17.2) and New Zealand European was the predominant ethnicity (83.4%), with smaller proportions of Māori (7.7%) and Pacific Islanders (1.7%). Between 2018 and 2023, the annual incidence of IBD was 32.4 per 100,000 person-years. The proportion of CD diagnosed each year decreased, and in 2023, the proportion of CD was equivalent (49%) to the proportion with UC. CONCLUSIONS: The incidence of IBD in Canterbury remains high, and the rates appeared stable over the six years 2018-2023, consistent with the stabilizing incidence stage of the 4-stage epidemiological model of IBD. Māori and Pacific Island ethnicities contributed a small number of cases of IBD, but the rates of IBD in these groups were higher than in previous studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansNew ZealandIncidenceAdultFemaleMaleMiddle AgedYoung AdultRetrospective StudiesAdolescentAged

Stichwörter der Autor:innen

EpidemiologyEthnicityIncidenceInflammatory bowel diseaseNew ZealandOceania

Autor:innen und Institutionen

  • Department of Medicine, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8140, New Zealand. angela.forbes@postgrad.otago.ac.nz.
  • Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand.
  • Department of Medicine, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8140, New Zealand.

Zitieren

APA

Forbes, A. J., Day, A. S., Frampton, C. M. A., & Gearry, R. B. (2025). Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018–2023. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08811-0

Vancouver

Forbes AJ, Day AS, Frampton CMA, Gearry RB. Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018–2023. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-024-08811-0

BibTeX
@article{Forbes2025,
  author = {Forbes, Angela J and Day, Andrew S and Frampton, Chris M A and Gearry, Richard B},
  title = {Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018–2023},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-024-08811-0}
}
Kostenlos starten →